Cancer Research UK - More than half of British vapers have now given up smoking tobacco
For the first time, less than half the people in Great Britain who use e-cigarettes also smoke tobacco cigarettes, according to new Action on Smoking and Health (ASH) figures.
The annual survey carried out by YouGov found around 2.9 million adults use e-cigarettes, with 1.3 million of these also smoking tobacco.
The main reason given in the study for using e-cigarettes was to help stop smoking entirely.
Professor Ann McNeill, from King’s College London, said finding that the majority of e-cigarette users are now ex-smokers was “encouraging news”. But the figures show many still ‘dual-use’ tobacco cigarettes alongside e-cigarettes.
Alyssa Best, Cancer Research UK’s tobacco policy adviser, said the findings were valuable for showing how and why people use e-cigarettes.
“The evidence so far shows that e-cigarettes are far safer than tobacco. So it’s great news that more and more vapers are going on to give up smoking altogether – which is the best thing a smoker can do for their health.
“Cancer Research UK is continuing to invest in research to find out more about their potential to help smokers ditch tobacco for good,” she said
Since 2012, the number of people using e-cigarettes has risen from 700,000 to 2.9 million.
But, Deborah Arnott, chief executive of ASH, said (link is external): “There are still 9 million smokers compared to only 1.5 million vapers who don’t smoke at all.”
The rise in people using e-cigarettes has also slowed in recent years, with fewer smokers understanding the reduced risk of vaping compared to smoking tobacco, said ASH.
“The rapid growth in e-cigarette use has come to an end while over a third of smokers have still never tried e-cigarettes, saying the main reasons are concerns about the safety and addictiveness of e-cigarettes,” said Arnott.
Many people over-estimate the risk posed by e-cigarettes, with just 13% of those involved in the study believing that the devices are a lot less harmful than smoking. More than a quarter (26%) think they are more or equally harmful.
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.